• Healthcare
  • Exchange
  • Working Group
  • Project

  • Pharma & Bioprinting

    Focusing on next-generation medical manufacturing, this group drives innovation in 3D-printed drugs, tissue models, and customized implants. It seeks to accelerate biotech applications and bridge lab-to-clinic workflows.

    This working group brings together experts from across the pharmaceutical and biotech sectors to explore how additive manufacturing and bioprinting can advance drug delivery and pre‑clinical research.

    We focus on developing innovative dosage forms, bioprinted tissue models, and practical AM solutions that enhance pharmaceutical processes. The group offers a collaborative space to share ideas, showcase applications, and jointly drive new technologies into real‑world practice.

    Dominic Duda

    Lead Technology Solutions
    Takeda Pharmaceutical AG

    Involved Members

  • [newsletter2go form_type=subscribe]